Blue Owl Capital Holdings LP Biomea Fusion, Inc. Transaction History
Blue Owl Capital Holdings LP
- $185 Million
- Q2 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 1,300,000 shares of BMEA stock, worth $2.15 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
1,300,000Holding current value
$2.15 Million% of portfolio
1.27%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
107Shares Held
16.8MCall Options Held
237KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.89 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.87 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.38 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.1 Million0.0% of portfolio
-
State Street Corp Boston, MA597KShares$985,6670.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.3M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...